Methods, systems, and devices for treating tinnitus with VNS pairing

US9522085B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9522085-B2
Application numberUS-201414527316-A
CountryUS
Kind codeB2
Filing dateOct 29, 2014
Priority dateJul 2, 2008
Publication dateDec 20, 2016
Grant dateDec 20, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of treating tinnitus comprising measuring a patient's hearing, determining the patient's hearing loss and the patient's tinnitus frequency using the measurements of the patient's hearing, programming a clinical controller with the measurements of the patient's hearing, selecting a plurality of therapeutic tones, where the therapeutic tones are selected to be at least a half-octave above or below of the patient's tinnitus frequency, setting an appropriate volume for each of the plurality of tones, repetitively playing each of the plurality of therapeutic tones, and pairing a vagus nerve stimulation pulse train with each playing of a therapeutic tone, thereby reducing the patient's perception of tinnitus.

First claim

Opening claim text (preview).

What is claimed is: 1. A system, comprising: a clinical controller providing therapy output signals including stimulation signals and sound signals; stimulator communicably connected to the clinical controller and receiving stimulation signals from the clinical controller; and headphones communicably connected to the clinical controller and receiving sound signals from the clinical controller, wherein the clinical controller provides a series of sound signals to the headphones and stimulation signals to the stimulator to relieve tinnitus symptoms, and the series of sound signals are configured to cause the headphones to output a series of discrete therapeutic tones separated by a quiet period, the discrete therapeutic tones having a frequency other than a predetermined tinnitus frequency of a patient having the tinnitus symptoms. 2. The system of claim 1 , wherein the clinical controller provides a series of sound signals to the headphones and stimulation signals to the stimulator so that the series of sound signals are paired with stimulation signals to relieve the tinnitus symptoms. 3. The system of claim 1 , wherein the clinical controller provides a series of sound signals to the headphones and stimulation signals to the stimulator so that the series of sound signals are temporally linked with stimulation signals to relieve the tinnitus symptoms. 4. The system of claim 1 , wherein the clinical controller provides a series of sound signals to the headphones and stimulation signals to the stimulator so that the series of sound signals are temporally proximate to stimulation signals to relieve the tinnitus symptoms. 5. The system of claim 1 , wherein: the clinical controller simultaneously provides a series of sound signals to the headphones and stimulation signals to stimulator to relieve tinnitus symptoms. 6. The system of claim 1 , wherein: the clinical controller provides respective sound signals to the headphones before providing respective stimulation signals to the stimulator to relieve the tinnitus symptoms. 7. The system of claim 1 , wherein: the clinical controller provides respective sound signals to the headphones after providing respective stimulation signals to the stimulator to relieve the tinnitus symptoms. 8. The system of claim 1 , wherein: the discrete therapeutic tones are pure tones. 9. The system of claim 1 , wherein: the stimulation signal is a stimulation control signal. 10. The system of claim 1 , wherein: the stimulation signal is a stimulation voltage. 11. A system comprising: tinnitus therapy software configured to cause the generation of stimulation ion signals and sound signals; a stimulator controllable by the tinnitus therapy software and receiving stimulation signals; and headphones controllable by the tinnitus therapy software and receiving sound signals; wherein the tinnitus therapy software is configured to cause the provision of a series of sound signals to the headphones and stimulation signals to the stimulator, and the series of sound signals are configured to cause the headphones to output a series of discrete therapeutic tones separated b a quiet period, the discrete therapeutic tones having a frequency other than a predetermined tinnitus frequency of a patient having the tinnitus symptoms. 12. The system of claim 11 , wherein the tinnitus therapy software is configured to cause the provision of a series of sound signals to the headphones and stimulation signals to the stimulator so that the series of sound signals are paired with the stimulation signals. 13. The system of claim 11 , wherein the tinnitus therapy software is configured to cause the provision of a series of sound signals to the headphones and stimulation signals to the stimulator so that the series of sound signals are temporally linked to the stimulation signals. 14. The system of claim 11 , wherein the tinnitus therapy software is configured to cause the provision of a series of sound signals to the headphones and stimulation signals to the stimulator so that the series of sound signals are temporally proximate to the stimulation signals. 15. The system of claim 11 , wherein: the tinnitus therapy software is configured to cause the provision of respective sound signals to the headphones before the provision of respective stimulation signals to the stimulator. 16. The system of claim 11 , wherein: the tinnitus therapy software is configured to cause the provision of respective sound signals to the headphones after the provision of respective stimulation signals to the stimulator. 17. The system of claim 11 , wherein: the tinnitus therapy software is configured to cause the provision of respective sound signals to the headphones while causing the provision of respective stimulation signals to the stimulator. 18. The system of claim 11 , wherein the tinnitus therapy software is configured to cause the provision of a series of sound signals to the headphones and stimulation signals to the stimulator so that the series of sound signals and the stimulation signals are synchronized. 19. The system of claim 11 , wherein: the stimulation signal is a stimulation control signal. 20. The system of claim 11 , wherein: the stimulation signal is a stimulation voltage. 21. A system comprising: a clinical controller for providing therapy output signals including stimulation signals and sound signals; a stimulator communicably connected to the clinical controller and receiving stimulation signals from the clinical controller; and a sound generator communicably connected to the clinical controller and receiving sound signals from the clinical controller; wherein the clinical controller is configured to provide a plurality of sound signals to the sound generator and stimulation signals to the stimulator to relieve tinnitus symptoms, and the clinical controller is configured to provide a plurality of sound signals such that the sound generator outputs respective therapeutic tones at least a half-octave above or below a predetermined tinnitus frequency of the patient having the tinnitus symptoms. 22. The system of claim 21 , wherein: the clinical controller is configured to provide the plurality of sound signals such that the sound generator outputs the respective therapeutic tones at least a half-octave above a predetermined tinnitus frequency of the patient having the tinnitus symptoms. 23. The system of claim 21 , wherein: the clinical controller is configured to provide the plurality of sound signals such that the sound generator outputs the respective therapeutic tones at least a half-octave below a predetermined tinnitus frequency of the patient having the tinnitus symptoms. 24. The system of claim 21 , wherein the clinical controller is configured to provide a plurality of sound signals to the sound generator and stimulation signals to the sound generator so that the series of sound signals are paired with stimulation signals to relieve the tinnitus symptoms. 25. The system of claim 21 , wherein the clinical controller is configured to provide a plurality of sound signals to the sound generator and stimulation signals to the sound generator so that the series of sound signals are temporally linked to stimulation signals to relieve the tinnitus symptoms. 26. The system of claim 21 , wherein the clinical controller is configured to provide a plurali

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9522085B2 cover?
A method of treating tinnitus comprising measuring a patient's hearing, determining the patient's hearing loss and the patient's tinnitus frequency using the measurements of the patient's hearing, programming a clinical controller with the measurements of the patient's hearing, selecting a plurality of therapeutic tones, where the therapeutic tones are selected to be at least a half-octave abov…
Who is the assignee on this patent?
Microtransponder Inc, Univ Texas
What technology area does this patent fall under?
Primary CPC classification A61N1/36053. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).